This clinical trial will measure Docosahexaenic Acid (DHA) levels in the blood and evaluate the relation to cognitive outcomes.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
DOUBLE
Enrollment
18
Universty of Kansas Medical Center
Kansas City, Kansas, United States
Red Blood Cell phospholipid weight percent of Docosahexaenoic Acid
Time frame: 6 months
Cognitive Measures - Executive Function, Language Development, and Behavior Assessment
Time frame: 6 months
Fatty Acid Desaturase (FADS) genotypes
Time frame: Once
Plasma Vitamin D levels
Time frame: 6 months
Iron levels in the blood
Time frame: 6 months
Blood Pressure
Time frame: 6 months
Heart Rate
Time frame: 6 months
Height and Weight
Time frame: 6 months
Recall of dietary intake at each study visit
Time frame: 6 months
Parental Product Assessment Questionnaire completed at Study Visit 2
Time frame: once
Medically-confirmed adverse events collected throughout the study period
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.